The engineered NK cells have demonstrated robust antitumor activity, with dose‐dependent eradication of cancer cells and an increase in cytokine secretion, including significant IFN‐gamma and Granzyme B levels (Golubovskaya et al., 2023). Here, GZMB is linked to cancer.